F.MED
Development of microsurgery assist robot which support surgeon's small vessel anastomosis.
Development of microsurgery assist robot which support surgeon's small vessel anastomosis.
F.MED is a Japan-based startup that is focused on the development of a microsurgery assist robot aimed at supporting small vessel anastomosis for surgeons. The company, founded in 2021, aims to address the challenges associated with microsurgery, which requires delicate and precise surgical tool manipulation. The current limitations hinder technique standardization and can be impacted by hand tremors.
The innovative solution that F.MED offers is a robotic system designed to replicate a surgeon's input motion while minimizing hand tremors and providing motion scale down. This technology is intended to improve surgical safety and efficacy while also enhancing a surgeon's learning curve. Ultimately, the company aims to increase the number of microsurgeons and improve the quality of life for patients undergoing microsurgery.
Recently, the company secured a significant ¥430.00M Series A investment on 09 July 2024, with participation from notable investors including Mitsubishi UFJ Capital, FFG Venture Business Partners, Oita Venture Capital, Higin Capital, JMTC Capital, Diamond Medino Capital, and Star Micronics. With a focus on Manufacturing and Robotics, F.MED is poised to make significant strides in the field of microsurgery robotics and contribute to advancements in surgical techniques for improved patient outcomes.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series A | ¥430.00M | 7 |
|
09 Jul 2024 |
No recent news or press coverage available for F.MED.
We care about your data, and we'd love to use cookies make your experience better.
